MKI67 and prostate carcinoma: Immunohistochemical analysis of paraffin-embedded sections of subcutaneous prostate cancer tumors demonstrated that Ki67 expression, which was clearly localized within the nucleus, was significantly suppressed by Ex–4, metformin and the combined treatment (Fig 2A and 2B).